PATENT CLAIM ANALYSIS

Application Number: 16220788
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-05
Patent Classification: ["424", "185100"]

Abstract:
The present invention pertains to a dendritic cell-based vaccine against rh-α-Syn, α-synuclein specific peptide antibodies and related vaccines, and methods of treating, inhibiting, and/or vaccinating against Parkinson's Disease (PD), or symptoms thereof.

Claim (Index 4):
The composition of  claim 1 , wherein the at least one peptide fragment of the \u03b1-synuclein protein comprises the amino acid sequence of SEQ ID NO:2.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 98.0
- Lexical Diversity: 1.17143
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15313810', '10915214', '11710248', '11185907', '12037081']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7136942508709185
- 35 USC 102 Novelty (BERT): 0.6453970270386762
- Combined Prediction Score: 0.7068645284876943
- Mean Citation Score: 373.830256
- Max Citation Score: 608.6337
- Similarity Product: 570.6467685282471

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test